Inhalation OctOber 2021 29
DPI development and
manufacturing services
Experic's experienced team provides customized
and scalable filling, packaging and logistics solu-
tions at clinical and commercial scale for reservoir
and single-dose dry powder inhalation devices.
From early development and manufacturing for
any single-dose unit, to clinical trial supplies and
logistics, Experic offers services that can solve dry
powder inhaler (DPI) manufacturing challenges,
accelerate time to market, and mitigate risk for
products with a range of properties, particle sizes,
doses and throughput requirements.
Experic LLC
US: +1 888 397-9733
https://expericservices.com
Supporting in vitro bioequivalence
e expansion at Intertek's Centre of Excellence for
Inhaled and Nasal Drug Development in Melbourn,
UK has focused on powerful in vitro analytical strat-
egies such as realistic flow profiles, lung dissolution
and Morphologically Directed Raman Spectros-
copy (MDRS) to help clients overcome challenges
of clinical bioequivalence studies. Our 30 years of
experience in supporting our clients' development
from concept through to marketing approval is built
on our strengths in method development/validation,
testing, stability, product characterization, device
screening, CMC studies, formulation development
and clinical manufacturing support.
Intertek
UK: +44 1763 261648
www.intertek.com